Seppo Mäkinen
b. 1952, M.Sc. Physical Chemistry
Full-time occupation: Professional Board Member
Positions of trust:
- Bittium Corporation, Member of the Board 2015.
- Optomed Corporation, Member of the Board 2019.
- VideoVisit Oy, Member of the Board 2018.
- Pathena S.A., partner 2017.
- Neurotar Oy, Member of the Board 2015.
Previous work history:
- Evondos Oy, Member of the Board 20162019.
- CBRA Genomics S.A., Member of the Board 20162019.
- Valirx Plc, Member of the Board 20132017,
Advisor 2017. - MedGroup Oy, Member of the Board 20132018.
- Ginolis Oy, Member of the Board 20112018, Chairman of the Board 20112018.
- Taikon Advisor, Managing Partner 20102016.
- Merieux Développement, Regional Partner, Nordics 20102016.
- Ventac Partners, Partner 20122016.
- Magnasense Technologies Oy, Member of the Board 20112015.
- Arcdia International Oy, Member of the Board 20112014.
- Balonco, Senior Advisor, owner 20122013.
- Mediracer Ltd., Chairman of the Board 20102013.
- RSP Systems, Member of the Board 20102011.
- Bio Fund Management Oy, Founding/Managing Partner 19972010.
- Sitra, Director in Life Science 19871997.
- Millipore/ Waters, Sales & Marketing 19831987.
- State Institute of Agricultural Chemistry, Chemist 19801983.
- Served as a Chairman or Member of the Board in Egalet A/S, SpinX Inc., Chempaq, Profos AG, Ilochip A/S, Exiqon A/S, KSH-Productor Oy, Merlin Diagnostika GmbH, Primex ASA, Rumen Oy, Millimed Inc., BioPorto A/S, Wallac, Kone Instruments, Rados Technologies, MAP Medical Technologies, Pharming NV, Bio-Orbit, Labmaster Oy, Viable Bioproducts, Fluilogic Oy.
Holdings Dec. 31, 2019:
Holds 4,308 shares in Bittium Corporation.
Independent as regards to the Company and its significant shareholders.